Skip to main content
$71.50 -$0.59 (-0.8%)

04:00 PM EDT on 06/18/21

Dr. Reddy's Laboratories Limited (ADR) (NYSE:RDY)

CAPS Rating: 2 out of 5

A global pharmaceutical company, which produces pharmaceutical ingredients and intermediates, finished dosage forms and biotechnology products and markets them globally. It conducts research in the areas of cancer, diabetes, cardiovascular disease etc.

Current Price $71.50 Mkt Cap $876.6B
Open $71.92 P/E Ratio 45.77
Prev. Close $5,284.60 Div. (Yield) $0.28 (0.4%)
Daily Range $71.17 - $71.92 Volume 215,330
52-Wk Range $51.12 - $74.42 Avg. Daily Vol. 122,881

Caps

How do you think NYSE:RDY will perform against the market?

Add Stock to CAPS Watchlist

All Players

425 Outperform
26 Underperform
 

All-Star Players

65 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:RDY Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

SapphireSeas (81.14)
Submitted December 24, 2009

40% of patents on proprietary drugs will expire by 2014. This stunning figure should be a windfall for Dr. Reddy's, which specializes in generics. Add to this the cheap costs of labor in India, and innovative model practiced by management, and we… More

SCSDogz (< 20)
Submitted September 16, 2008

I see bright things for this company in the future. They have a 4 biologics in the pipeline and 3 acquisitions over the last couple years. But these will not bear fruit for a while. Also RDY is still a young global company that needs to deal with… More

Recent Community Commentary

Read the most recent pitches from players about RDY.

Recs

0
Member Avatar TMFjimhalley (61.52) Submitted: 5/5/2021 8:40:36 PM : Outperform Start Price: $70.02 NYSE:RDY Score: +2.33

Company has been increasing revenue, margins and profits but seems to be underpriced with a relatively low price-to-earnings ratio.

Recs

0
Member Avatar jfdihansen (40.01) Submitted: 11/22/2014 1:43:42 PM : Outperform Start Price: $55.44 NYSE:RDY Score: -71.30

Net asset value is less that stock price

Recs

0
Member Avatar racoveanul (70.31) Submitted: 7/3/2014 11:49:50 AM : Outperform Start Price: $41.78 NYSE:RDY Score: -38.31

I picked this stock because it is rated 10 by Stockscouter, it has a dividend and a beta computed by Yahoo Finance of more than 1.

Leaderboard

Find the members with the highest scoring picks in RDY.

Score Leader

athome4

athome4 (59.65) Score: +495.70

The Score Leader is the player with the highest score across all their picks in RDY.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
athome4 59.65 10/10/2008 Outperform 5Y $7.25 +886.36% +390.66% +495.70 0 Comment
niwhsa 79.29 11/20/2008 Outperform 3Y $6.99 +923.27% +431.59% +491.68 0 Comment
yeraz 66.58 10/13/2008 Outperform 5Y $7.73 +824.88% +350.59% +474.29 1 Comment
MedullaOblongata 71.07 11/5/2008 5/4/2010 Outperform 5Y $8.12 +780.33% +329.02% +451.31 0 Comment
biotech4ever 22.19 3/20/2009 Outperform 5Y $7.37 +870.52% +436.18% +434.34 0 Comment
XMFHamp 99.93 10/9/2008 Outperform NS $8.24 +767.54% +337.48% +430.06 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. snazzysnazz 71.33 3/20/2009 Outperform 5Y $7.36 +871.73% +442.91% +428.82 0 Comment
Trimalerus 77.13 3/23/2009 9/27/2020 Outperform 5Y $7.50 +852.91% +432.45% +420.46 1 Comment
jenculbertson 69.44 10/16/2008 Outperform 1Y $8.09 +783.30% +380.29% +403.02 0 Comment
apodeictic < 20 10/22/2008 Outperform 1Y $8.37 +754.48% +356.49% +397.99 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for RDY.